Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 3 clinical trials
Featured trial
Clinical Study Protocol Abbvie M11-352

Clinical Study Protocol Abbvie M11-352

  • 332 views
  • 25 Mar, 2021
  • 1 location
Atrasentan in Patients With IgA Nephropathy (ALIGN)

The ALIGN Study is a phase 3, double-blind, placebo-controlled study to compare the efficacy and safety of atrasentan to placebo in patients with IgA nephropathy (IgAN) at risk of progressive

renal function
nephropathy
  • 47 views
  • 04 Oct, 2022
  • 119 locations
Atrasentan in Patients With Proteinuric Glomerular Diseases (AFFINITY)

The AFFINITY Study is a phase 2, open-label, basket study to evaluate the efficacy and safety of atrasentan in patients with proteinuric glomerular disease who are at risk of progressive loss of

ras inhibitor
corticosteroids
type 2 diabetes
renal function
atrasentan
  • 31 views
  • 04 Oct, 2022
  • 36 locations